Skip to content
MedsAcross

Medicine

Bepotastine 15 mg/mL eye drops

Bepotastine · Ophthalmic
Available on requestPrescription onlyUS FDAGeneric name

Bepotastine 15 mg/mL eye drops is a generic prescription medicine for ophthalmic use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 15°C to 25°C (59°F to 77°F).

Key facts

Active ingredient (INN)
Bepotastine
Brand
Sold under the generic name
Strength
15 mg/mL
Dosage form
Eye drops
Route
Ophthalmic
Packs
1 bottle and 7 more
Manufacturers
Alembic PharmaceuticalsIndiaBausch & LombBausch & Lomb AmericasMylan Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 15°C to 25°C (59°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 May 2021
Identifiers
RxCUI 863038DailyMed set ID de111d74-c740-47b3-adc7-4b855df2c561, 995f4fe0-d861-4137-8090-a8ffc71c46f4, 75178670-aa57-45f9-94d5-efcf8305e683 +2NDC 46708-598, 24208-630, 0378-7055 +2Application ANDA214588, NDA022288, ANDA206220

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle in 1 carton / 5 mL in 1 bottle46708-598-05Alembic PharmaceuticalsIndia18 July 2023
1 bottle in 1 carton / 10 mL in 1 bottle46708-598-10Alembic PharmaceuticalsIndia5 April 2023
1 bottle in 1 carton / 5 mL in 1 bottle62332-598-05Alembic PharmaceuticalsIndia18 July 2023
1 bottle in 1 carton / 10 mL in 1 bottle62332-598-10Alembic PharmaceuticalsIndia5 April 2023
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper24208-630-05Bausch & Lomb28 May 2021
1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper24208-630-10Bausch & Lomb28 May 2021
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper82260-630-05Bausch & Lomb Americas28 May 2021
1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper82260-630-10Bausch & Lomb Americas28 May 2021
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper0378-7055-35Mylan Pharmaceuticals28 May 2021
1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper0378-7055-67Mylan Pharmaceuticals28 May 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 September 2009Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Bepotastine 15 mg/mL eye drops.

Compare 1

Other strengths and forms of Bepotastine

Clinical summary

Bepotastine is a histamine-1 receptor antagonist indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis. It is available as eye drops and ophthalmic solution. MedsAcross supplies Bepotastine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Bepotastine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Bepotastine 15 mg/mL eye drops for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.